Articles by Tyler Menichiello

1. On The Ground At BPI: Jacqualyn Schulman, Ph.D., On Accelerating Clonal CLD 10/9/2026

   An interview with Jacqualyn Schulman, Ph.D., a principal scientist at Bristol Myers Squibb (BMS), on her presentation at BPI 2026, “Fast-Tracking CHO Cell Line Development Using Integrated Engineering Strategies.”

2. AstraZeneca's Focus On Predictive Control, Semi-Autonomous Processing 9/30/2026

   This article captures key takeaways from a BioProcess International keynote by Preeya Boppana, director of MSAT process analytics and laboratories at AstraZeneca, titled “Transforming Biologics Manufacturing: Leveraging Predictive Analytics and Advanced Process Control for Next-Generation Operations.”

3. Prioritizing Quality Over Everything 9/28/2026

   Regulatory compliance and cGMP manufacturing expert Tatyana Matveeva, Ph.D., explains the role and importance of a quality unit in an organization, as well as what happens when it’s compromised.

4. Evaluating The Levers Driving Productivity In Bioprocessing 8/28/2026

   Experts discuss where productivity gains can be achieved and how development teams should seek to improve process performance in this recap of the Bioprocess Online Live event "The Levers And Tradeoffs That Drive Process Productivity."

5. Overcoming Recovery Challenges In AAV Production 8/26/2026

   Siren Biotechnology's SVP of vector development, Nathalie Clément, Ph.D., explains the challenge of purifying AAV capsids and the ways developers are optimizing vector recovery.

6. Preserving Tacit Knowledge In ADC Tech Transfers 8/19/2026

   ADCs built on proprietary platforms risk losing process-specific knowledge during a tech transfer. See what advice panelists from the Bioprocess Online Live event "Ensuring Successful Technology Transfer In ADC Development" shared with the audience on preserving this implicit knowledge.

7. 08.11.26 -- June 2026 — CDMO Opportunities And Threats Report 8/11/2026

   08/11/26

8. Multispecific Manufacturability Starts With Molecular Design 7/21/2026

   AP Biosciences’ VP of antibody discovery, Jhong-Jhe You, Ph.D., explains the key design elements of multispecific antibodies and how they affect product developability.

9. On The Ground At BIO 2026: Johanna Kaufmann, Ph.D., On The Oncology Modality Puzzle 7/10/2026

   At the 2026 BIO International Convention, Bioprocess Online caught up with Johanna Kaufmann, Ph.D., CSO at Deck Bio, a company developing multi-targeted T-cell engagers for solid tumors.

10. BIO 2026: Modernizing The FDA And Bolstering The Workforce 7/10/2026

    Bioprocess Online's chief editor, Tyler Menichiello, shares his key takeaways from the 2026 BIO International Convention in San Diego.